Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

[Recurrent pulmonary edema after umbilical cord blood transplantation in a patient with infant acute lymphoblastic leukemia].

Sawa D, Nishikawa T, Nakashima K, Morita H, Ito N, Fukano R, Okamura J, Inagaki J.

Rinsho Ketsueki. 2013 Mar;54(3):273-8. Japanese.

PMID:
23676642
2.

A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation.

Kim ID, Egawa H, Marui Y, Kaihara S, Haga H, Lin YW, Kudoh K, Kiuchi T, Uemoto S, Tanaka K.

Am J Transplant. 2002 Sep;2(8):796-800.

3.

[Recurrent pulmonary edema in a patient with acute lymphoblastic leukemia after syngeneic bone marrow transplantation].

Takahashi H, Sekiguchi H, Kai S, Ikuta K, Sasaki H, Matsuyama S.

Rinsho Ketsueki. 1992 Mar;33(3):354-9. Japanese.

PMID:
1578640
4.

Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.

Kato K, Yoshimi A, Ito E, Oki K, Hara J, Nagatoshi Y, Kikuchi A, Kobayashi R, Nagamura-Inoue T, Kai S, Azuma H, Takanashi M, Isoyama K, Kato S; Japan Cord Blood Bank Network.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1814-21. doi: 10.1016/j.bbmt.2011.05.013. Epub 2011 May 25.

5.

Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.

Mori T, Aisa Y, Nakazato T, Yamazaki R, Shimizu T, Mihara A, Yamane A, Ikeda Y, Okamoto S.

Transplant Proc. 2007 Jun;39(5):1615-9.

PMID:
17580201
6.

The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.

Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P.

Blood Cells. 1994;20(2-3):275-83; discussion 284.

PMID:
7749107
7.

Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.

Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J; COBLT Steering Committee.

Biol Blood Marrow Transplant. 2005 Aug;11(8):637-46.

8.

[Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].

Tang XF, Luan Z, Xu SX, Wu NH, Huang YZ, Wang K.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):5-8. Chinese.

PMID:
18289460
9.

Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up.

Iori AP, Arcese W, Milano F, Calabrese E, Torelli GF, Barberi W, Mascolo MG, De Felice L, Screnci M, Lucarelli B, Malandruccolo L, Perrone MP, Salvatori S, Laurenti L, Iannella E, Ricci R, Moleti ML, Foà R.

Haematologica. 2007 Aug;92(8):1051-8. Epub 2007 Jul 20.

11.
12.

[Cord blood stem cell transplantation for infantile acute lymphoblastic leukemia after primary cytomegalovirus infection].

Goi K, Sugita K, Miyamoto N, Karakida N, Nakamura M, Kojika S, Iijima K, Kagami K, Nakazawa S.

Rinsho Ketsueki. 1997 Nov;38(11):1229-33. Japanese.

PMID:
9423343
13.

Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.

Jacobsohn DA, Hewlett B, Ranalli M, Seshadri R, Duerst R, Kletzel M.

Bone Marrow Transplant. 2004 Nov;34(10):901-7.

PMID:
15361908
14.

Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.

Yamada MF, Miyamura K, Fujiwara T, Kohata K, Okitsu Y, Ohguchi H, Yamamoto J, Yokoyama H, Tomiya Y, Ishizawa K, Kameoka J, Harigae H.

Transplant Proc. 2008 Dec;40(10):3637-42. doi: 10.1016/j.transproceed.2008.06.102.

PMID:
19100456
15.

Haploidentical transplantation for acute lymphoblastic leukemia in childhood.

Klingebiel T, Handgretinger R, Lang P, Bader P, Niethammer D.

Blood Rev. 2004 Sep;18(3):181-92. Review.

PMID:
15183902
16.

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.

Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ.

Blood. 2009 Mar 26;113(13):2902-5. doi: 10.1182/blood-2008-10-184093. Epub 2009 Jan 28.

17.

[Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].

Kuroki F, Goto H, Yanagimachi M, Kajiwara R, Fujii H, Isaki S, Takahashi H, Ikuta K, Yokota S.

Rinsho Ketsueki. 2006 Jul;47(7):639-44. Japanese.

PMID:
16910574
18.

Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.

Berglund S, Le Blanc K, Remberger M, Gertow J, Uzunel M, Svenberg P, Winiarski J, Ljungman P, Ringdén O, Uhlin M, Mattsson J.

Transplantation. 2012 Nov 27;94(10):1066-74. doi: 10.1097/TP.0b013e31826c39b2.

PMID:
23076550
19.

Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.

Nordlander A, Mattsson J, Ringdén O, Leblanc K, Gustafsson B, Ljungman P, Svenberg P, Svennilson J, Remberger M.

Biol Blood Marrow Transplant. 2004 Mar;10(3):195-203.

20.

Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.

Bradstock KF, Hertzberg MS, Kerridge IH, Svennilson J, McGurgan M, Huang G, Antonenas V, Gottlieb DJ.

Intern Med J. 2006 Jun;36(6):355-61.

PMID:
16732860

Supplemental Content

Support Center